ACR GUIDELINES Bundle (free trial)

Kawasaki Disease

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 5 of 5

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at Copyright © 2022 All rights reserved ACRKAW02223a Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the American College of Rheumatology, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; GC, glucocorticoids; IVIG, intravenous immunoglobulin; KD, Kawasaki disease; NSAID, non-steroidal anti- inflammatory drugs; UA, urinalysis; WBC, white blood cell Source Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatolog y/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis & Rheumatolog y, 2022 Mar 8. doi: 10.1002/art.42041. Epub ahead of print.

Articles in this issue

Links on this page

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Kawasaki Disease